Sphingosine Kinase Activity and Sphingosine-1 Phosphate Production in Rat Pancreatic Islets and INS-1 Cells
Response to Cytokines
- 1Department of Pharmacology and Toxicology, The State University of New York, Buffalo, New York
- 2Department of Pediatrics, School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, New York
- Address correspondence and reprint requests to Suzanne G. Laychock, 102 Farber Hall, The State University of New York at Buffalo, School of Medicine, 3435 Main St., Buffalo, NY 14214. E-mail: laychock{at}buffalo.edu
Abstract
Sphingosine-1 phosphate (S1P) is a bioactive sphingolipid with the potential to mobilize Ca2+, to inhibit apoptosis, and to promote mitogenesis. Sphingosine kinase (SPHK) and S1P were characterized in INS-1 insulinoma cells and isolated rat islets of Langerhans. SPHK activity increased in INS-1 cell homogenates treated with interleukin-1β (IL-1β) or tumor necrosis factor-α (TNF-α), and responses were additive. IL-1β or TNF-α increased islet SPHK activity within 15 min to 1 h; activity remained elevated after 8 h. SPHK2 was the predominant active isoform in INS-1 cells; little or no SPHK1 activity was detected. Cytokines increased endogenous S1P biosynthesis in 32Pi-prelabeled INS-1 cells, and cycloheximide inhibited the response after 8 h, suggesting that protein synthesis mediated the response. There was no [32P]S1P release from cells. Compared with basal values, IL-1β and TNF-α induced increases in SPHK1a mRNA levels relative to 18S ribosomal RNA in INS-1 cells within 1 h; relative SPHK2 mRNA levels were unchanged after cytokine treatment. IL-1β, but not TNF-α, induced relative SPHK1a mRNA expression levels within 1 h in islets, whereas SPHK2 mRNA levels were unchanged. Thus, IL-1β and TNF-α induced an early and sustained increase in SPHK activity in INS-1 cells and isolated islets, suggesting that S1P plays a role in the pathological response of pancreatic β-cells to cytokines.
- EDG, endothelial differentiation gene–encoded receptor
- FAF-BSA, fatty acid–free BSA
- FBS, fetal bovine serum
- IL-1β, interleukin-1β
- PKC, protein kinase C
- S1P, sphingosine-1 phosphate
- SPHK sphingosine kinase
- TLC, thin-layer chromatography
- TNF-α, tumor necrosis factor-α
Footnotes
-
- Accepted January 28, 2005.
- Received August 19, 2004.
- DIABETES














